_id
690dace4ccc777a4e85d09c6
Ticker
ALB
Name
Albemarle Corp
Exchange
NYSE
Address
4250 Congress Street, Charlotte, NC, United States, 28209
Country
USA
Sector
Basic Materials
Industry
Specialty Chemicals
Currency
USD
Website
https://www.albemarle.com
Description
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics, organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates in the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemicals products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Last Close
133.21
Volume
3060151
Current Price
134.59
Change
1.035958261391784
Last Updated
2025-11-28T12:05:22.594Z
Image
data:image/webp;base64,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
Ipo Date
1994-02-17T00:00:00.000Z
Market Cap
14936994816
Next Dividend Date
2026-01-02T00:00:00.000Z
Dividend Frequency
Quarterly
Dividend Rate
0.405
Dividend Yield
1.2036555464744783
Sentiment
0.798158208955224
Sentiment Sources
67
Rating
3.4286
Target Price
105.0991
Strong Buy
6
Buy
3
Hold
17
Sell
1
Strong Sell
1
Current Quarter
2025-09-30
Revenue
1307829000
Cost Of Revenue
1190219000
Gross Profit
117610000
Operating Expenses
334596000
Operating Income
-216986000
Interest Expense
50959000
Pretax Income
-178506000
Net Income
-160694000
Eps
-1.3654586395887327
Dividends Per Share
89343000
Shares Outstanding
117697540
Income Tax Expense
-30565000
EBITDA
36936000
Operating Margin
-16.59131277865837
Total Other Income Expense Net
38480000
Cash
1931758000
Short Term Investments
-
Receivables
841178000
Inventories
1532622000
Total Current Assets
4554905000
Property Plant Equipment
9348267000
Total Assets
17148285000
Payables
903171000
Short Term Debt
474512000
Long Term Debt
3181009000
Total Liabilities
6879227000
Equity
9996113000
Depreciation
164483000
Change In Working Capital
151141000
Cash From Operations
355602000
Capital Expenditures
132164000
Cash From Investing
-152979000
Cash From Financing
-90531000
Net Change In Cash
124929000
PE
-
PB
1.5845383250469458
ROE
-1.6075648604612611
ROA
-0.9370849621405288
FCF
223438000
Fcf Percent
0.17084649445760874
Piotroski FScore
2
Health Score
47
Deep Value Investing Score
5.5
Defensive Investing Score
8
Dividend Investing Score
3.5
Economic Moat Investing Score
6.3
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
4
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1307829000
Quarters > 0 > income Statement > cost Of Revenue
1190219000
Quarters > 0 > income Statement > gross Profit
117610000
Quarters > 0 > income Statement > operating Expenses
334596000
Quarters > 0 > income Statement > operating Income
-216986000
Quarters > 0 > income Statement > interest Expense
50959000
Quarters > 0 > income Statement > pretax Income
-178506000
Quarters > 0 > income Statement > net Income
-160694000
Quarters > 0 > income Statement > eps
-1.3654586395887327
Quarters > 0 > income Statement > dividends Per Share
89343000
Quarters > 0 > income Statement > shares Outstanding
117685000
Quarters > 0 > income Statement > income Tax Expense
-30565000
Quarters > 0 > income Statement > EBITDA
36936000
Quarters > 0 > income Statement > operating Margin
-16.59131277865837
Quarters > 0 > income Statement > total Other Income Expense Net
38480000
Quarters > 0 > balance Sheet > cash
1931758000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
841178000
Quarters > 0 > balance Sheet > inventories
1532622000
Quarters > 0 > balance Sheet > total Current Assets
4554905000
Quarters > 0 > balance Sheet > property Plant Equipment
9348267000
Quarters > 0 > balance Sheet > total Assets
17148285000
Quarters > 0 > balance Sheet > payables
903171000
Quarters > 0 > balance Sheet > short Term Debt
474512000
Quarters > 0 > balance Sheet > long Term Debt
3181009000
Quarters > 0 > balance Sheet > total Liabilities
6879227000
Quarters > 0 > balance Sheet > equity
9996113000
Quarters > 0 > cash Flow > net Income
-160694000
Quarters > 0 > cash Flow > depreciation
164483000
Quarters > 0 > cash Flow > change In Working Capital
151141000
Quarters > 0 > cash Flow > cash From Operations
355602000
Quarters > 0 > cash Flow > capital Expenditures
132164000
Quarters > 0 > cash Flow > cash From Investing
-152979000
Quarters > 0 > cash Flow > cash From Financing
-90531000
Quarters > 0 > cash Flow > net Change In Cash
124929000
Quarters > 0 > ratios > PE
-1.3654586395887327
Quarters > 0 > ratios > PB
1.5845383250469458
Quarters > 0 > ratios > ROE
-1.6075648604612611
Quarters > 0 > ratios > ROA
-0.9370849621405288
Quarters > 0 > ratios > FCF
223438000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.17084649445760874
Quarters > 0 > health Score
47
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1329992000
Quarters > 1 > income Statement > cost Of Revenue
1133116000
Quarters > 1 > income Statement > gross Profit
196876000
Quarters > 1 > income Statement > operating Expenses
149349000
Quarters > 1 > income Statement > operating Income
47527000
Quarters > 1 > income Statement > interest Expense
49939000
Quarters > 1 > income Statement > pretax Income
69287000
Quarters > 1 > income Statement > net Income
22897000
Quarters > 1 > income Statement > eps
0.1945948242892959
Quarters > 1 > income Statement > dividends Per Share
89324000
Quarters > 1 > income Statement > shares Outstanding
117665000
Quarters > 1 > income Statement > income Tax Expense
34094000
Quarters > 1 > income Statement > EBITDA
209699000
Quarters > 1 > income Statement > operating Margin
3.573480141233932
Quarters > 1 > income Statement > total Other Income Expense Net
21760000
Quarters > 1 > balance Sheet > cash
1806829000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
879738000
Quarters > 1 > balance Sheet > inventories
1640925000
Quarters > 1 > balance Sheet > total Current Assets
4505187000
Quarters > 1 > balance Sheet > property Plant Equipment
9252894000
Quarters > 1 > balance Sheet > total Assets
17291927000
Quarters > 1 > balance Sheet > payables
858781000
Quarters > 1 > balance Sheet > short Term Debt
444911000
Quarters > 1 > balance Sheet > long Term Debt
3178111000
Quarters > 1 > balance Sheet > total Liabilities
6792943000
Quarters > 1 > balance Sheet > equity
10240526000
Quarters > 1 > cash Flow > net Income
35193000
Quarters > 1 > cash Flow > depreciation
168731000
Quarters > 1 > cash Flow > change In Working Capital
243260000
Quarters > 1 > cash Flow > cash From Operations
-7203000
Quarters > 1 > cash Flow > capital Expenditures
119628000
Quarters > 1 > cash Flow > cash From Investing
362915000
Quarters > 1 > cash Flow > cash From Financing
-90634000
Quarters > 1 > cash Flow > net Change In Cash
288318000
Quarters > 1 > ratios > PE
0.1945948242892959
Quarters > 1 > ratios > PB
1.546456925161852
Quarters > 1 > ratios > ROE
0.22359203033125447
Quarters > 1 > ratios > ROA
0.1324143919876599
Quarters > 1 > ratios > FCF
-126831000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.09536222774272327
Quarters > 1 > health Score
46
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1076881000
Quarters > 2 > income Statement > cost Of Revenue
920582000
Quarters > 2 > income Statement > gross Profit
156299000
Quarters > 2 > income Statement > operating Expenses
136538000
Quarters > 2 > income Statement > operating Income
19761000
Quarters > 2 > income Statement > interest Expense
48977000
Quarters > 2 > income Statement > pretax Income
-18966000
Quarters > 2 > income Statement > net Income
41348000
Quarters > 2 > income Statement > eps
0.35158967033153915
Quarters > 2 > income Statement > dividends Per Share
89295000
Quarters > 2 > income Statement > shares Outstanding
117603000
Quarters > 2 > income Statement > income Tax Expense
-3978000
Quarters > 2 > income Statement > EBITDA
191765000
Quarters > 2 > income Statement > operating Margin
1.8350216969191584
Quarters > 2 > income Statement > total Other Income Expense Net
-38727000
Quarters > 2 > balance Sheet > cash
1518511000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
807855000
Quarters > 2 > balance Sheet > inventories
1656365000
Quarters > 2 > balance Sheet > total Current Assets
4107282000
Quarters > 2 > balance Sheet > property Plant Equipment
9303039000
Quarters > 2 > balance Sheet > total Assets
16999258000
Quarters > 2 > balance Sheet > payables
917954000
Quarters > 2 > balance Sheet > short Term Debt
410477000
Quarters > 2 > balance Sheet > long Term Debt
3128655000
Quarters > 2 > balance Sheet > total Liabilities
6724916000
Quarters > 2 > balance Sheet > equity
10028239000
Quarters > 2 > cash Flow > net Income
49298000
Quarters > 2 > cash Flow > depreciation
161754000
Quarters > 2 > cash Flow > change In Working Capital
-21992000
Quarters > 2 > cash Flow > cash From Operations
545383000
Quarters > 2 > cash Flow > capital Expenditures
182624000
Quarters > 2 > cash Flow > cash From Investing
-179303000
Quarters > 2 > cash Flow > cash From Financing
-120006000
Quarters > 2 > cash Flow > net Change In Cash
326281000
Quarters > 2 > ratios > PE
0.35158967033153915
Quarters > 2 > ratios > PB
1.5783616415603976
Quarters > 2 > ratios > ROE
0.4123156618026355
Quarters > 2 > ratios > ROA
0.24323414586683725
Quarters > 2 > ratios > FCF
362759000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.336860804490004
Quarters > 2 > health Score
66
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1231713000
Quarters > 3 > income Statement > cost Of Revenue
1093500000
Quarters > 3 > income Statement > gross Profit
138213000
Quarters > 3 > income Statement > operating Expenses
133811000
Quarters > 3 > income Statement > operating Income
4402000
Quarters > 3 > income Statement > interest Expense
44703000
Quarters > 3 > income Statement > pretax Income
95724000
Quarters > 3 > income Statement > net Income
75293000
Quarters > 3 > income Statement > eps
0.6395776526252304
Quarters > 3 > income Statement > dividends Per Share
89288000
Quarters > 3 > income Statement > shares Outstanding
117723000
Quarters > 3 > income Statement > income Tax Expense
10613000
Quarters > 3 > income Statement > EBITDA
284536000
Quarters > 3 > income Statement > operating Margin
0.3573884500691314
Quarters > 3 > income Statement > total Other Income Expense Net
91322000
Quarters > 3 > balance Sheet > cash
1192230000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1065560000
Quarters > 3 > balance Sheet > inventories
1502531000
Quarters > 3 > balance Sheet > total Current Assets
3842262000
Quarters > 3 > balance Sheet > property Plant Equipment
9450309000
Quarters > 3 > balance Sheet > total Assets
16609649000
Quarters > 3 > balance Sheet > payables
943887000
Quarters > 3 > balance Sheet > short Term Debt
398023000
Quarters > 3 > balance Sheet > long Term Debt
3118142000
Quarters > 3 > balance Sheet > total Liabilities
6409961000
Quarters > 3 > balance Sheet > equity
9961517000
Quarters > 3 > cash Flow > net Income
85111000
Quarters > 3 > cash Flow > depreciation
163106000
Quarters > 3 > cash Flow > change In Working Capital
535125000
Quarters > 3 > cash Flow > cash From Operations
674000
Quarters > 3 > cash Flow > capital Expenditures
355728000
Quarters > 3 > cash Flow > cash From Investing
-327810000
Quarters > 3 > cash Flow > cash From Financing
-92881000
Quarters > 3 > cash Flow > net Change In Cash
-472289000
Quarters > 3 > ratios > PE
0.6395776526252304
Quarters > 3 > ratios > PB
1.5905547889944875
Quarters > 3 > ratios > ROE
0.7558386940462983
Quarters > 3 > ratios > ROA
0.4533087965916679
Quarters > 3 > ratios > FCF
-355054000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
-0.28826033337311535
Quarters > 3 > health Score
47
Valuation > metrics > PE
-1.3654586395887327
Valuation > metrics > PB
1.5845383250469458
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-1.6075648604612611
Profitability > metrics > ROA
-3.527933074345129
Profitability > metrics > Net Margin
-0.12287080344601627
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6881901995305575
Risk > metrics > Interest Coverage
-4.25805058968975
Risk > final Score
31
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.3062068705210126
Liquidity > metrics > Quick Ratio
2.1937434083167173
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
5
Prev Profitabilities > 1
10
Prev Profitabilities > 2
17
Prev Risks > 0
52
Prev Risks > 1
50
Prev Risks > 2
48
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T00:24:38.076Z
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics, organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates in the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemicals products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
0.405Next Payout:
Jan 2, 2026Yield:
1.2037 %Lithium Deficit Could Boost Albemarle (ALB) Stock, Says UBS Yahoo! Finance Canada
Read more āAlbemarle (ALB) Just Overtook the 20-Day Moving Average Zacks Investment Research
Read more āShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$105.0991
Analyst Picks
Strong Buy
6
Buy
3
Hold
17
Sell
1
Strong Sell
1
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ⤠1
High ā„ 3
Return on Equity (ROE)
-
Very Low
Low ⤠5%
High ā„ 25%
Return on Assets (ROA)
-
Very Low
Low ⤠2%
High ā„ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ⤠5%
High ā„ 15%
Debt to Equity
-
Medium
Low ā„ 1
High ⤠0.3
* Institutions hold a combined 64.70% of the total shares of Albemarle Corp
1.
Vanguard Group Inc(12.5147%)
since
2025/06/30
2.
Capital World Investors(7.0018%)
since
2025/06/30
3.
BlackRock Inc(6.981%)
since
2025/06/30
4.
State Street Corp(5.6402%)
since
2025/06/30
5.
Franklin Resources Inc(4.9039%)
since
2025/06/30
6.
Capital Research Global Investors(3.5266%)
since
2025/06/30
7.
PRIMECAP Management Company(2.8091%)
since
2025/06/30
8.
Amvescap Plc.(2.5128%)
since
2025/06/30
9.
Geode Capital Management, LLC(2.5104%)
since
2025/06/30
10.
ProShare Advisors LLC(2.4388%)
since
2025/06/30
11.
UBS Group AG(2.0247%)
since
2025/06/30
12.
Morgan Stanley - Brokerage Accounts(2.0202%)
since
2025/06/30
13.
Bank of America Corp(2.003%)
since
2025/06/30
14.
Squarepoint Ops LLC(1.4701%)
since
2025/06/30
15.
Dimensional Fund Advisors, Inc.(1.2093%)
since
2025/06/30
16.
Earnest Partners LLC(1.2089%)
since
2025/06/30
17.
Northern Trust Corp(1.0544%)
since
2025/06/30
18.
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.(1.0024%)
since
2025/06/30
19.
Charles Schwab Investment Management Inc(0.9535%)
since
2025/06/30
20.
PGGM Investments(0.9092%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.